Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ABCL

AbCellera Biologics Inc

May 29 • 04:00PM ET

6.17

+0.44 7.68 %

Healthcare • Biotechnology • Canada • Small • NASD

Peers: RCUS TNGX CGON KYMR NUVL RYTM BMRN INCY KRYS AXSM

| Held by: IBB SPDW IDNA GWX ONEQ BBC AVUS PDN AVSC IBBQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.48	Insider Own	22.83%	Shs Outstand	303.95M	Perf Week	20.04%
Market Cap	1.88B	Forward P/E	-	EPS next Y	-0.64	Insider Trans	0.00%	Shs Float	234.76M	Perf Month	61.52%
Enterprise Value	1.49B	PEG	-	EPS next Q	-0.14	Inst Own	41.55%	Short Float	18.30%	Perf Quarter	70.91%
Income	-143.96M	P/S	23.79	EPS this Y	-20.41%	Inst Trans	2.24%	Short Ratio	7.60	Perf Half Y	70.44%
Sales	79.21M	P/B	2.00	EPS next Y	-9.23%	ROA	-10.86%	Short Interest	42.95M	Perf YTD	80.41%
Book/sh	3.09	P/C	3.56	EPS next 5Y	-18.48%	ROE	-14.68%	52W High	6.51 -5.30%	Perf Year	202.45%
Cash/sh	1.73	P/FCF	-	EPS past 3/5Y	- -	ROIC	-13.42%	52W Low	1.98 211.62%	Perf 3Y	-9.26%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-46.31% -20.27%	Gross Margin	61.02%	Volatility	8.93% 9.79%	Perf 5Y	-77.00%
Dividend TTM	-	EV/Sales	18.87	EPS Y/Y TTM	15.53%	Oper. Margin	-267.61%	ATR (14)	0.44	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	13.89	Sales Y/Y TTM	242.66%	Profit Margin	-181.75%	RSI (14)	74.26	Recom	1.22
Dividend Gr. 3/5Y	- -	Current Ratio	14.05	EPS Q/Q	7.05%	SMA20	25.93%	Beta	1.14	Target Price	10.43
Payout	-	Debt/Eq	0.15	Sales Q/Q	96.34%	SMA50	48.25%	Rel Volume	1.64	Prev Close	5.73
Employees	562	LT Debt/Eq	0.14	Earnings	May 11 AMC	SMA200	47.84%	Avg Volume	5.65M	Price	6.17
IPO	Dec 11, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	18.32% 53.63%	Trades		Volume	9,255,059	Change	7.68%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)